The combination of suicide gene therapy and radiation enhances the killing of nasopharyngeal carcinoma xenographs

Journal of Radiation Research

Volumn 45, Issue 2, 2004, Pages 281-289

  Xia, Jiahui ^a   Xia, Kun ^a   Feng, Yong ^a   Tang, Aifa ^a   Tang, Yaoyun ^a   Wu, Lingqian ^a   Liang, Desheng ^a   Cai, Fang ^a   Pan, Qian ^a   Long, Zhigao ^a   Dai, Heping ^a   Zhang, Yunyi ^a   Zhao, Suping ^a   Chen, Zhuchu ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Egr 1 promoter; Nasopharyngeal carcinoma (NPC); Radiation; Suicide gene therapy

Indexed keywords

GENE EXPRESSION; GENE THERAPY; MAMMALS; TUMORS; YEAST;

ASIAN COUNTRIES; CD-UPRT; EFFECTIVE APPROACHES; EGR-1 PROMOTER; GENES EXPRESSION; NASOPHARYNGEAL CARCINOMA; NUDE MICE; SOUTHERN CHINA; SUICIDE GENE THERAPY;

RADIATION;

EARLY GROWTH RESPONSE FACTOR 1;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RADIOTHERAPY; CANCER THERAPY; CONTROLLED STUDY; DRUG EFFECT; EXPRESSION VECTOR; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; NASOPHARYNX CARCINOMA; PROMOTER REGION; STATISTICAL SIGNIFICANCE; SUICIDE GENE THERAPY; XERORADIOGRAPHY; YEAST CELL;

ANIMALIA; CUCUMBER MOSAIC VIRUS; MUS MUSCULUS; VECTORS;

EID: 4544268990     PISSN: 04493060     EISSN: None     Source Type: Journal    
DOI: 10.1269/jrr.45.281     Document Type: Article

References (30)

1. Hirayama, T. (1978) Descriptive and analytical epidemiology of nasopharyngeal cancer. IARC Sci. Publ. 20: 167-189.
2. Freytag, S. O., Khil, M., Stricker, H., Peabody, J., Menon, M., DePeralta-Venturina, M., Nafziger, D., Pegg, J., Paielli, D., Brown, S., Barton, K., Lu, M., Aguilar-Cordova, E. and Kim, J. H. (2002) Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer. Cancer Res. 62: 4968-4976.
3. Kilstrup, M., Meng, L. M., Neuhard, J. and Nygaard, P. (1989) Genetic evidence for a repressor of synthesis of cytosine deaminase and purine biosynthesis enzymes in Escherichia coli. J. Bacteriol. 171: 2124-2127.
4. Mullen, C. A., Kilstrup, M. and Blaese, R. M. (1992) Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc. Natl. Acad. Sci. U.S.A. 89: 33-37.
5. Coustere, C., Mentre, F., Sommadossi, J. P., Diasio, R. B. and Steimer, J. L. (1991) A mathematical model of the kinetics of 5-fluorouracil and its metabolites in cancer patients. Cancer Chemother. Pharmacol. 28: 123-129.
6. Tiraby, M., Cazaux, C., Baron, M., Drocourt, D., Reynes, J. P. and Tiraby, G. (1998) Concomitant expression of E. coli cytosine deaminase and uracil phosphoribosyltransferase improves the cytotoxicity of 5-fluorocytosine. FEMS Microbiol. Lett. 167:41-49.
7. Chung-Faye, G. A., Chen, M. J., Green, N. K., Burton, A., Anderson, D, Mautner, V., Searle, P. F. and Kerr, D. J. (2001) In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase. Gene Ther. 8: 1547-1554.
8. Kievit, E., Bershad, E., Ng, E., Sethna, P., Dev, I., Lawrence, T. S. and Rehemtulla, A. (1999) Superiority of yeast over bacterial cytosine deaminase for enzyme/prodrug gene therapy in colon cancer xenografts. Cancer Res. 59: 1417-1421.
9. Hamstra, D. A., Rice, D. J., Fahmy, S., Ross, B. D. and Rehemtulla, A. (1999) Enzyme/prodrug therapy for head and neck cancer using a catalytically superior cytosine deaminase. Hum. Gene Ther. 10: 1993-2003.
10. Erbs, P., Regulier, E., Kintz, J., Leroy, P., Poitevin, Y., Exinger, F., Jund, R. and Mehtali, M. (2000) In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase/uracil phosphoribosyltransferase fusion gene. Cancer Res. 60: 3813-3822.
11. Rogulski, K. R., Kim, J. H., Kim, S. H. and Freytag, S. O. (1997) Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity. Hum. Gene Ther. 8: 73-85.
12. Rogulski, K. R., Zhang, K., Kolozsvary, A., Kim, J. H. and Freytag, S. O. (1997) Pronounced antitumor effects and tumor radiosensitization of double suicide gene therapy. Clin. Cancer Res. 3: 2081-2088.
13. Akuzawa, N., Kurabayashi, M., Ohyama, Y., Arai, M. and Nagai, R. (2000) Zinc finger transcription factor Egr-1 activates Flt-1 gene expression in THP-1 cells on induction for macrophage differentiation. Arterioscler. Thromb. Vasc. Biol. 20: 377-384.
14. Datta, R., Taneja, N., Sukhatme, V. P., Qureshi, S. A., Weichselbaum, R. and Kufe, D. W. (1993) Reactive oxygen intermediates target CC(A/T)6GG sequences to mediate activation of the early growth response 1 transcription factor gene by ionizing radiation. Proc. Natl. Acad. Sci. U.S.A. 90: 2419-2422.
15. Greco, O., Marples, B., Dachs, G. U., Williams, K. J., Patterson, A. V. and Scott, S. D. (2002) Novel chimeric gene promoters responsive to hypoxia and ionizing radiation. Gene Ther. 9: 1403-1411.
16. Huang, Lei. (2000) Study on functional elements of bisatellite microchromosome and foreign gene expression in homologous region of bisatellite microchromosome - the short arm of d, g group chromosome. Docter Thesis, pp. 2-52
17. Sizhong, Z., Xiukung, G. and Yi, Z. (1983) Cytogenetic studies on an epithelial cell line derived from poorly differentiated nasopharyngeal carcinoma. Int. J. Cancer 31: 587-590.
18. Teng, Z. P., Ooka, T., Huang, D. P. and Zeng, Y. (1996) Detection of Epstein-Barr Virus DNA in well and poorly differentiated nasopharyngeal carcinoma cell lines. Virus Genes 13(1): 53-60.
19. Kim, J. K., Petin, V. G. and Zhurakovskaya, G. P. (2001) Exposure rate as a determinant of the synergistic interaction of heat combined with ionizing or ultraviolet radiation in cell killing. J Radiat. Res. 42: 361-369.
20. Suzuki, S., Miura, Y., Mizuno, S. and Furusawa, Y. (2002) Models for mixed irradiation with a 'reciprocal-time' pattern of the repair function. J. Radiat. Res. 43: 257-267.
21. Walker, J. T., Todd, P. and Walker, O. A. (2002) Heritable non-lethal damage to cultured human cells irradiated with heavy ions. J. Radiat. Res. 43(Suppl.): S187-S191.
22. Mizumoto, K., Qian, L. W., Zhang, L., Nagai, E., Kura, S. and Tanaka, M. (2002) A nitroimidazole derivative, PR-350, enhances the killing of pancreatic cancer cells exposed to high-dose irradiation under hypoxia. J. Radiat. Res. 43: 43-51.
23. Li, J. H., Lax, S. A., Kim, J., Klamut, H. and Liu, F. F. (1999) The effects of combining ionizing radiation and adenoviral p53 therapy in nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 43: 607-616.
24. Hsieh, Y. H., Wu, C. J., Chow, K. P., Tsai, C. L. and Chang, Y. S. (2003) Electroporation-mediated and EBV LMP1-regulated gene therapy in a syngenic mouse tumor model. Cancer Gene Ther. 10: 626-636.
25. Weinrib, L., Li, J. H., Donovan, J., Huang, D. and Liu, F. F. (2001) Cisplatin chemotherapy plus adenoviral p53 gene therapy in EBV-positive and -negative nasopharyngeal carcinoma. Cancer Gene Ther. 8: 352-360.
26. Qi, V., Weinrib, L., Ma, N., Li, J. H., Klamut, H. and Liu, F. F. (2001) Adenoviral p53 gene therapy promotes heat-induced apoptosis in a nasopharyngeal carcinoma cell line. Int. J. Hyperthermia 17: 38-47.
27. Wu, C. J., Leu, C. Y., Liu, S. T., Chow, K. P., Meng, C. L. and Chang, Y. S. (1998) Transcriptional activation of NF-kappa B activity by Epstein-Barr virus (EBV) LMP1 as a selective therapeutic strategy for EBV-associated diseases. Gene Ther. 5: 905-912.
28. Joki, T., Nakamura, M. and Ohno, T. (1995) Activation of the radiosensitive EGR-1 promoter induces expression of the herpes simplex virus thymidine kinase gene and sensitivity of human glioma cells to ganciclovir. Hum. Gene Ther. 6: 1507-1513.
29. Seki, M., Iwakawa, J., Cheng, H. and Cheng, P. W. (2002) p53 and PTEN/MMAC1/TEP1 gene therapy of human prostate PC-3 carcinoma xenograft, using transferrin-facilitated lipofection gene delivery strategy. Hum. Gene Ther. 13: 761-773.
30. Chen, Y., Xue, Z., Zheng, D., Xia, K., Zhao, Y., Liu, T., Long, Z. and Xia, J. (2003) Sodium chloride modified silica nanoparticles as a non-viral vector with a high efficiency of DNA transfer into cells. Curr. Gene Ther. 3: 273-279.